Press release titled: "NLS Pharmaceutics CEO Issues Letter to Shareholders." - Form 6-K -December 29, 2023 at 04:39 pm EST
Zürich, Switzerland, December 29, 2023 - NLS Pharmaceutics Ltd. , a Swiss clinical-stage biopharmaceutical company, focused on the discovery and development of innovative therapies for...